Miochol-E (Acetylcholine Chloride)

Acetylcholine chloride, the active ingredient in Miochol‑E, is a cholinergic agonist presented as a sterile ophthalmic solution for intraocular use. Originating from the European Union market, it produces pupil constriction and facilitates aqueous humor outflow, thereby supporting intra‑operative miosis and adjunctive glaucoma therapy.

GNH USA supplies Miochol‑E as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality‑assured distribution across diverse healthcare settings and complying with local regulatory requirements through robust logistics and cold‑chain where applicable.

Miochol‑E, a cholinergic agonist used in ophthalmic care, is indicated for conditions that benefit from pharmacologically induced pupil constriction and improved aqueous outflow.

- Induction of miosis during ophthalmic surgery: provides controlled pupil constriction to enhance surgical visualization and instrument access. - Adjunctive treatment of glaucoma: facilitates aqueous humor drainage, helping to lower intraocular pressure when used with standard therapy. - Facilitation of intraocular procedures: aids in procedures such as laser iridotomy and intra‑ocular lens implantation by stabilizing pupil size.

Miochol‑E may cause ocular and systemic reactions; reported adverse events are categorized by frequency.

Common Side Effects: - Eye irritation: mild burning or stinging sensation after instillation. - Transient blurred vision: temporary reduction in visual acuity. - Mild headache: occasional frontal discomfort. - Increased lacrimation: excess tearing.

Serious or Rare Side Effects: - Severe ocular inflammation: uveitis or keratitis requiring immediate attention. - Systemic cholinergic toxicity: bradycardia, hypotension, or bronchospasm in susceptible individuals.

Prior to using Miochol‑E, clinicians should evaluate patient history and adhere to safety guidelines.

- Contraindicated in patients with known hypersensitivity: avoid use. - Use with caution in narrow‑angle glaucoma: monitor intraocular pressure closely. - Avoid in severe cardiovascular disease: assess risk of systemic cholinergic effects. - Do not combine with other miotic agents without supervision: risk of excessive pupil constriction. - Store at room temperature: keep in the original container, protect from light and moisture.

Miochol‑E can interact with other medications that affect cholinergic pathways or intraocular pressure.

Major Interactions (Avoid): - Concurrent use with systemic anticholinergic drugs: may reduce efficacy of Miochol‑E. - Combination with other cholinergic agonists: risk of excessive muscarinic stimulation.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: may have additive effects on intraocular pressure. - Topical anesthetics: may increase corneal irritation when used together. - Systemic cholinesterase inhibitors: monitor for enhanced cholinergic response.